Oct 10 (Reuters) - IRadimed Corp IRMD.O :
* IRADIMED CORPORATION WITHDRAWS 510(K) WITH PLANS TO
RESUBMIT
AFTER FURTHER DISCUSSIONS WITH FDA
* IRADIMED CORP - SEES THIRD-QUARTER REVENUE TO BE
APPROXIMATELY
$13.4 MILLION, UP 23% FROM PRIOR YEAR
* IRADIMED CORP - ORDERS BOOKED IN QUARTER EXCEEDED OUR
SHIPMENTS
* IRADIMED CORP - ANNOUNCED THAT COMPANY VOLUNTARILY
WITHDREW ITS
510(K) APPLICATION ON OCTOBER 5, 2022, FOR ITS NEXT-GENERATION
MR IV PUMP
* IRADIMED CORP - FDA REQUESTED ADDITIONAL INFORMATION THAT
WAS
NOT FEASIBLE TO PROVIDE WITHIN FDA'S REVIEW DEADLINE
Source text for Eikon: ID:nGNXbKtwmS
Further company coverage: IRMD.O
((Reuters.Briefs@thomsonreuters.com;))